Papers

13

Total Citations

150

H-Index

6

About

Dr. Kae Jack Tay is a pioneering urologic surgeon and researcher whose work centers on advancing minimally invasive, image-guided interventions for prostate and bladder cancers. His major contributions lie in the development and validation of focal therapy—particularly in-bore MR-guided focused ultrasound for prostate cancer, where his phase I trial demonstrated excellent safety and preserved functional outcomes at two-year follow-up (50 citations). Dr. Tay has also been instrumental in refining diagnostic accuracy through multiparametric MRI-ultrasound fusion and stereotactic robot-assisted transperineal prostate biopsy, showing that targeted biopsy outperforms systematic approaches (23 citations). His systematic review and meta-analysis of off-clamp versus on-clamp robot-assisted partial nephrectomy (16 citations) provides critical evidence for nephron-sparing surgery. Additionally, his work on combination MRI-targeted and transperineal template biopsy for restaging low-risk prostate cancer in active surveillance (16 citations) has helped reduce overtreatment. With over 145 cumulative citations, Dr. Tay’s research bridges cutting-edge robotics, imaging, and focal therapy to improve oncologic control while minimizing morbidity—a transformative approach in urologic oncology.

Research Focus

Key Achievements

6
H-Index
13
Papers
150
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Focal Therapy for Prostate Cancer with In-Bore MR–guided Focused Ultrasound: Two-Year Follow-up of a Phase I Trial—Complications and Functional Outcomes
50 citations · 2017
📈 Most Prolific Year: 2020 (4 Papers)
🤝 Key Collaborators: 50
🏛 Institutions: National Cancer Centre Singapore, Singapore General Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago